1-3 of 3
Zachary T Ball
Close
Sort by
Journal Articles

Combining Atovaquone with Intensive Conventional Chemotherapy for Pediatric Acute Myeloid Leukemia (AML) Is Feasible and Well Tolerated

Alexandra McLean Stevens, Eric Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Allison Weisnicht, Noah J Keogh, Michelle C Alozie, Hailey H Oviedo, Alan K Gonzalez, Alicia Mangubat-Medina, Haopei Wang, Eunji Jo, Cara A Rabik, Claire Bocchini, Susan Hilsenbeck, Zachary T Ball, Todd M. Cooper, Michele Redell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2312.
https://doi.org/10.1182/blood-2021-146057
Published: 2021
Journal Articles

Targeting Activated Signaling Pathways for the Treatment of IKZF1 -Deleted B Lymphoblastic Leukemia

Rohit Gupta, BA, Jason H. Rogers, MS, Xin Long, PhD, Geraldo Medrano, BS, Jaime M. Reyes, BS, Michele Redell, MD PhD, Zachary T Ball, PhD, Margaret Goodell, PhD, Rachel E. Rau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3789.
https://doi.org/10.1182/blood-2019-127209
Published: 2019
Journal Articles

A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment

Michael J Krueger, BS, Matthew Minus, BS, Wei Liu, PhD, Xin Long, PhD, Alexandra M. Stevens, MD, Mikhail I. Kolosov, BS, Edward Allan R. Sison, MD, David John Tweardy, MD, Zachary T. Ball, PhD, Michele S. Redell, MD PhD
Journal: Blood
Blood (2015) 126 (23): 569.
https://doi.org/10.1182/blood.V126.23.569.569
Published: 2015